U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Search results

Items: 1 to 20 of 44

  • The following terms were not found in MeSH: 112885, 112885-41-3.
1.

3-Oxoacyl-(Acyl-Carrier-Protein) Synthase

An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41.

Year introduced: 1998(1975)

3.

4-Nitrophenylphosphatase

An enzyme that catalyzes the hydrolysis of nitrophenyl phosphates to nitrophenols. At acid pH it is probably ACID PHOSPHATASE (EC 3.1.3.2); at alkaline pH it is probably ALKALINE PHOSPHATASE (EC 3.1.3.1). EC 3.1.3.41.

Year introduced: 1994

4.

endothelin-3 (1-41)amide [Supplementary Concept]

an endothelin precursor

Date introduced: November 20, 1995

5.

midostaurin [Supplementary Concept]

Date introduced: August 7, 2014

6.

(2-cyano-3-(methylamino)phenyl)oxoacetic acid [Supplementary Concept]

orally active antiallergy agent; RN given is for Na salt

Date introduced: August 25, 1981

7.

Isoamylase

An enzyme that hydrolyzes 1,6-alpha-glucosidic branch linkages in glycogen, amylopectin, and their beta-limit dextrins. It is distinguished from pullulanase (EC 3.2.1.41) by its inability to attack pullulan and by the feeble action of alpha-limit dextrins. It is distinguished from amylopectin 6-glucanohydrolase (EC 3.2.1.69) by its action on glycogen. With EC 3.2.1.69, it produces the activity called "debranching enzyme". EC 3.2.1.68.

Year introduced: 1991(1975)

8.
9.

3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione [Supplementary Concept]

a glycogen synthase kinase-3 inhibitor with antineoplastic activity; structure in first source

Date introduced: February 10, 2015

10.

Ro 41-3696 [Supplementary Concept]

a partial benzodiazepine receptor agonist

Date introduced: March 17, 1995

11.

tromantadine [Supplementary Concept]

Date introduced: January 1, 1973

12.

Ketanserin

A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.

Year introduced: 1987

13.
15.
16.

C3-cleaving proteinase, 39 kDa [Supplementary Concept]

cleaves C3, the third compnent of complement; shows amino acid sequence identities with 4 regions of procathepsin L; expressed on surface of melanoma cells; amino acid sequence given in first source; 39 kDa from murine melanoma cell line, 41 kDa from human melanoma cell line shares antigenic determinants with 39 kDa proteinase and cathepsin L

Date introduced: February 9, 1996

17.

Ro 41-5253 [Supplementary Concept]

a synthetic retinoid with antiviral activity; a selective RAR alpha antagonist; structure given in first source

Date introduced: January 19, 1994

18.

amylopullulanase [Supplementary Concept]

has both pullulanase (EC 3.2.1.41) and alpha-amylase (EC 3.2.1.1) activities; apuA encodes alkaline amylopullulanase from Bacillus; amino acid sequence in first source; GenBank M97665

Date introduced: September 3, 1993

19.

Ro 41-9067 [Supplementary Concept]

structure given in first source

Date introduced: August 16, 1993

20.

proendothelin 3 [Supplementary Concept]

contains 41 amino acids in humans

Date introduced: December 17, 1992

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Loading ...